This independent RP-HPLC lab test confirms Semaglutide 10mg from Orbitrex Peptides at 99.793% purity. The analysis was conducted by Chromate on January 5, 2026.
Semaglutide is a GLP-1 receptor agonist researched for its potential effects on metabolic regulation, weight management, and glycemic control. A purity level of 99.793% indicates minimal contamination and high-grade synthesis.
Endotoxin testing confirmed 0.1301 EU/mg, and heavy metal analysis showed < 50 ppb, demonstrating safety standards for research applications. The full certificate of analysis is available for download on this page.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.